Submit Content

Please check your e-mail for a link to activate your account.

Research report Acaricide Market Growth, 2016-2026

Acaricides are pesticides that kill ticks and mites and help animals gain immunity against various infectious diseases. Acaricides work by interfering with the nerves, muscles, respiration and growth of mites and ticks. Cattle farmers need to use acaricides to prevent tick infestation and injury to animals. Losses due to tick infestations can be considerable and ticks cause paralysis and physical damage to cattle. Some acaricides might be toxic to fishes and other wildlife and have to be applied cautiously to prevent damage to ecosystem.

A large variety of diseases are transmitted by ticks that severely affect the livestock. Major diseases transmitted by ticks include theileriosis, heartwater, anaplasmosis, and babesiosis. In order to stop the transmission of diseases, the ticks need to be killed before they feed on vulnerable animals and transmit diseases to other organism. Use of chemical acaricides is the most common and effective method of killing ticks.

Emerging economies such as Asia pacific, Latin America and Eastern Europe represent major markets for acaricides due to high cattle farming in these regions. Rising population is triggering high demand for agricultural output and meat consumption globally. Growth in crop and meat consumption is further expected to boost the global acaricides market over the forecast period of 2016-2026.

Drivers and Restraints

Emerging markets such as Brazil, India and China, with rapidly growing populations and faster economic growth, have steadily increased their meat as well as crop/ grain consumption. The increase in consumption of meat is expected to be major driver for acaricides market growth globally. The rising demand for dairy products and new developments in crop industry are also among key driving factors for the acaricides market. However, certain species of ticks and mites have developed resistance to acaricides, which pose certain limitations to acaricides market growth. High raw material cost and various stringent government regulations are also expected to hamper the growth of acaricides market over the forecast period.

Request Free Report Sample@ http://www.futuremarketinsights.com/reports/sample/rep-gb-1535

Market Segmentation

Acaricides market is segmented on the basis of type, application, mode of application and region. On the basis of type, the acaricides market is segmented into the following segments:

  • Natural
  • Arsenicals
  • Chlorinated hydrocarbons
  • Organo-phosphorous compounds
  • Others

On the basis of application, the acaricides market is segmented into the following segments:

  • Animal husbandry
  • Agriculture
  • Others

On the basis of mode of application, the acaricides market is segmented into the following segments:

  • Dipping vat
  • Spray
  • Spray race or Spray dip machine
  • Hand dressing
  • Others

Request For TOC@ http://www.futuremarketinsights.com/toc/rep-gb-1535

Regional Outlook

Regionally, the acaricides market is segmented into seven key regions namely- North America, Latin America, Western Europe, Eastern Europe, Asia Pacific excluding Japan, Middle East & Africa and Japan. Emerging economies of Asia Pacific, Latin America and Eastern Europe are expected to represent fastest growth in global acaricides market. China and India are major consumers of acaricides due to intensive cattle farming. The use of acaricides to the control ticks growth has improved the viability of cattle farming in these countries. In contrast, demand for acaricides in North America, Western Europe, Japan, and South Korea will be moderate due to market maturity and already high use rates.

Market Players

Some of the key players included in this study of global acaricides market are Bayer AG, Syngenta, Monsanto, DuPont, BASF SE, The Dow Chemical Company, Makhteshim, Nufarm, Sumitomo Chemicals and Arysta Lifescience.


Parenteral Packaging Market Will hit at a CAGR of 11.2% from 2016 to 2026

The global parenteral packaging market was valued at 7.9 Bn in 2015 and is expected to grow at a year-over-year rate of 9.5% to reach 8.6 Bn in 2016. North America will continue to be the most lucrative market, representing 27.4% revenue share of the market in 2016. Western Europe, the second largest market for parenteral packaging, will grow by 10.8% in 2016.

Increasing popularity of plastics & polymers over glass for production of primary packaging material and global expansion of pharmaceuticals industry will continue to fuel the growth of the market in 2016. Increase in the prevalence of epidemic diseases such as cancer, diabetes, hepatic failure and chronic intestinal diseases will also play a role in ramping up demand for parenteral packaging. Favourable government policies, combined with rising adoption of injection-based treatment will also continue to influence the market positively. Growing geriatric population will also play a role in the overall growth of the parenteral packaging market.

Request Free Report Sample@ http://www.futuremarketinsights.com/reports/sample/rep-gb-1258

On the basis of product, the prefilled syringes & cartridges segment will continue to hold the leading revenue share. This segment is expected to grow by 10.1% in 2016 to reach 1.2 Bn in revenues.

On the basis of material, the global parenteral packaging market is largely segmented into plastic & polymer and glass segments. Use of glass for parenteral packaging is witnessing a decline, as plastic & polymer are more durable and resistant to shocks and impacts. The plastic & polymer segment will witness a growth rate of 10.5% in 2016, whereas the glass segment is expected to grow by 8.7%.

On the basis of packaging type, the global parenteral packaging market is mostly non-tangible in nature, owing to the needs of the patients as well as storage conditions for drugs. However, the packaging type are primarily segmented into large volume parenteral and small volume parenteral, with the former accounting for higher revenue share of the market.

Visit For TOC@ http://www.futuremarketinsights.com/toc/rep-gb-1258

While North America and Western Europe will continue to ramp up demand, growth will also be substantial in emerging economies of APEJ. Increasing healthcare spending and presence of a large geriatric population segment will positively influence market growth in APEJ, with total revenues set to reach 2.0 Bn in 2016.

Key participants in the global parenteral packaging market include Gerresheimer AG, Schott AG, Becton, Unilife Corporation, Inc, Dickinson and Company, Ypsomed Holding AG, West Pharmaceutical Services, Inc., SiO2 Medical Products, Terumo Corporation, Ompi, Stevanato Group and Nipro Corporation.

Long-term Outlook: The global parenteral packaging market is anticipated to increase at a CAGR of 11.2% during the forecast period 2016-2026.

Discussion With Analyst@ http://www.futuremarketinsights.com/askus/rep-gb-1258


Potassium Sulfate Market 10-Year Forecast

Potassium sulfate is a non-flammable and water soluble white crystalline salt which is predominantly used in the production of fertilizers. Potassium sulfate fertilizer is the most widely used chloride free fertilizer among all types of potash fertilizers manufactured and consumed globally. The quality characteristics that potassium sulfate fertilizers such as low salt index, draught resistant, suitability for saline soil and chloride sensitive crops make it a highly sought after fertilizer among all types of chloride free fertilizers. Moreover, potassium sulfate is used in the manufacturing of glass. Furthermore, potassium sulfate is used as a flash reducer in the artillery propellant charges as it reduces flareback, muzzle flash and blast overpressure. Potassium sulfate is widely available in different grades such as technical, food, agricultural and pharmaceutical for use in different applications. However, the agricultural grade is the highest consumed grade of potassium phosphate due to its dominant demand from the fertilizers industry. The growing demand for potassium sulfate from the fertilizer industry is expected to drive the global potassium sulfate market in the next few years.

Global Potassium Sulfate Market: Drivers and Restraints

Water soluble fertilizers form the largest application group of potassium sulfate. The growing demand from fertigation application supported by rising adoption of micro irrigation systems is anticipated to propel the global demand for water soluble fertilizers. Moreover, the increasing demand for better yield due to decreasing arable land, rapidly rising world population and high demand for biofuels is predicted to further fuel the demand for water soluble fertilizers across the globe. Water soluble fertilizers are formulations of mineral fertilizers that are completely soluble in water. These fertilizers can be sprayed or applied on crops to improve the quality and yield of crops such as pulses, cereals, fruits and vegetables. Crops require several nutrients in varied concentrations as per different seasons. The water soluble fertilizers ensure a consistent supply of essential nutrients to crops. Water soluble fertilizers are applied using micro irrigation systems. Owing to its high solubility, potassium sulfate fertilizers are predicted to emerge as the fastest growing market segment of the water soluble fertilizers across the globe during the forecast period. All such positive attributes are resulting in an increase in the demand for potassium sulfate fertilizers which is further driving the demand for potassium sulfate across the world.

Request Free Report Sample@ http://www.futuremarketinsights.com/reports/sample/rep-gb-1534

Global Potassium Sulfate Market: Segmentation

Depending on the application, global potassium sulfate market has been segmented into the following key market segments:

  • Agriculture
  • Turf Management
  • Industrial

Global Potassium Sulfate Market: Regional Outlook

Asia Pacific is predicted to emerge as the fastest growing market for potassium sulfate in the next few years. The main reason for this is the growing demand for water soluble fertilizes, especially potassium sulfate fertilizers, in China, India and South East Asian countries such as Indonesia, Malaysia, Thailand and Vietnam due to growing need for better yield for fulfilling the food demand of the rising population. Moreover, the countries such as Brazil, Argentina, South Africa, Nigeria, Jordan, Egypt, and Israel are growingly focusing on improving the agriculture production. Furthermore, the U.S. and European economies are showing signs of recovery after a severe economic downturn. All these factors are creating a positive outlook for the global agriculture and fertilizer industry. Subsequently, the demand for potassium sulfate in fertilizer is predicted to rise in the coming years and therefore, the global potassium sulfate market is expected to record a significant growth in the near future.

Request For TOC@ http://www.futuremarketinsights.com/toc/rep-gb-1534

Global Potassium Sulfate Market: Market Players

Some of the major companies operating in the global potassium sulfate market are mentioned below

  • K+S KALI GmbH
  • Great Salt Lake Minerals
  • Big Quill Resources
  • Potash Corporation
  • SESODA
  • Akash Purochem Private Limited
  • SDIC XINJIANG LUOBUPO POTASH CO.,LTD.
  • Qingshang Chemical (kaifeng) Co., Ltd.

Agar Market Projected to Reach CAGR of 2.6% 2016-2026

Agar being used as an essential natural ingredient in food and beverages; in technical application; in bacteriological and many other sectors is propelling the demand for agar. Future Market Insights (FMI) estimates global agar volume to surpass 10,968.8 tonnes by 2016 end and represent market value of over US$ 220,838.5.

In global market, the demand for agar is dominated by food and beverage segment which especially includes bakery and dairy products. Companies dealing in agar products are promoting agar as an ingredient which has natural and health benefits. Apart from its wide application in food and beverages industry, its application is also increasing in cosmetics, pharmaceuticals, media culture and medical analytics.

Food and beverage industry is the largest segment which are preferring agar as a thickener and stabilising agent and is expected to account for over 84.0% value share in 2016. Moreover, food and beverage segment is expected to reach 9,216.8 tonnes in 2016 – an increase of 1.5% over 2015.

Request Free Report Sample@ http://www.futuremarketinsights.com/reports/sample/rep-gb-330

The form segment includes strips and powder. With powder segment registering significant revenue generation and estimated to account for 63.5% value share in 2016. FMI estimates global consumption of agar powder to surpass 6,969.7 tonnes by 2016 end, an increase of 1.7% in 2016 over 2015.

In terms of consumption, Western Europe is the largest consumer with the total consumption estimated at 3,012.7 tonnes in 2015. Among all the regions, APEJ is predicted to observe robust growth over forecast period 2016–2026.

Agarmex, New Zealand Manuka Group, Hispanagar, Acroyali Holdings Qingdao Co. Ltd., Industrias Roko, S.A, Neogen, Merck Group, Agarindo Bogatama, Setexam and Norevo Gmbh are the major companies identified across the value chain in the global agar market. Companies are also emphasising on research and development for application of agar in technical applications.

Request For TOC@ http://www.futuremarketinsights.com/toc/rep-gb-330

Long-Term outlook: FMI seeks a positive long-term outlook on global agar market and anticipated global value of agar to surpass US$ 357,091.6 by 2026. Volume-wise, the global agar market is estimated to expand at a CAGR of 2.6% through 2026.


Global Non-invasive Prenatal Testing (NIPT) Market Expected to Reach US$ 2.38 Bn in 2022

According to a new market report published by Persistence Market Research “Global Market Study on Non-invasive Prenatal Testing (NIPT) Market 2015 - 2022”, the global NIPT market was valued at US$ 0.53 Bn in 2013 and is expected to expand at a CAGR of 15.0% from 2015 to 2022 to reach US$ 2.38 Bn in 2022.

Non-invasive prenatal diagnosis refers to screening test recommended for the detection of certain specific chromosomal aneuploidies from maternal blood sample. Over the past two years, the global prenatal testing market has witnessed a paradigm shift from conventional prenatal screening and diagnostic methods such as maternal serum screening, nuchal translucency (NT) scan, amniocentesis, and chorionic villus sampling (CVS) to non-invasive prenatal testing. This was mainly because of the advantages associated with NIPTs such as safety, accuracy, and no risk of miscarriage during the genetic screening test for common chromosomal abnormalities (trisomy 21, trisomy 18, trisomy 13, monosomy X, etc.). Currently, NIPTs are recommended only to high-risk pregnant women; however, several companies are targeting their tests toward both low-risk and high-risk pregnancies.

Interested in report: Please follow the below the links to meet your requirements; Request for the Report Sample: http://www.persistencemarketresearch.com/samples/11218

BambniTest, Harmony, informaSeq, MaterniT21 PLUS, NIFTY, Panorama, PrenaTest, verifi, and VisibiliT are the commercially available NIPTs in the global market. These tests are based on the direct analysis of cell-free fetal DNA in the maternal blood. MaterniT21 (MaterniT21 PLUS) was the first non-invasive prenatal Laboratory Developed Test (LDT) that was launched by Sequenom, Inc. in October 2011 for the detection of trisomy 21. MaterniT21 PLUS gained advantage of being the first mover in the NIPT market and was the most accepted NIPT in 2013, accounting for 36.1% share of the market in terms of revenue. It is likely to lose market share during the forecast period from 2015 to 2022 due to increasing market penetration by other NIPTs such as NIFTY, Panorama, and verifi.

View TOC (table of content), Figures and Tables of the Report: http://www.persistencemarketresearch.com/market-research/non-invasive-prenatal-testing-nipt-market/toc

In terms of volume, MaterniT21 test was the leading segment in 2013. However, the number of MaterniT21 tests performed would decrease during the forecast period from 2015 to 2022. This is majorly due to commercialization of other non-invasive tests and their positioning strategies. Due to the recent CFDA approval for BambniTest (Berry Genomics), the number of tests performed would increase during the forecast period.

Advantages offered by NIPT such as non-invasiveness, high accuracy and early detection; rising awareness, increasing market penetration in highly untapped countries in Europe and Asia; and continuous increase in average maternal age are the major factors expected to drive the growth of the global NIPT market during the forecast period. However, the market could face significant ethical and regulatory hurdles associated with the implementation of NIPT because of the belief that it is likely to increase the incidence of abortions. Therefore, various professional organizations such as the American College of Obstetricians and Gynecologists (ACOG), the International Society for Prenatal Diagnosis, the Japan Society of Obstetrics and Gynecology, and genetic counselors across the world have set up guidelines that limit the use of non-invasive prenatal testing only to pregnant women at high risk of chromosomal aneuploidies.

Browse Full Report: http://www.persistencemarketresearch.com/market-research/non-invasive-prenatal-testing-nipt-market.asp

Several companies are investing in the development of non-invasive prenatal tests. Quest Diagnostics is developing a non-invasive test by utilizing the patented technology of Sequenom, Inc. and the test is likely to be commercialized in 2015. Sequenom, Inc., Illumina, Inc. (Verinata Health, Inc.), Ariosa Diagnostics, Natera, Inc., BGI Diagnostics, LifeCodexx AG, LabCorp, and Berry Genomics are the major companies operating in the global non-invasive prenatal tests market.

To Buy this Full Report: http://www.persistencemarketresearch.com/checkout/11218

The global non-invasive prenatal testing market is segmented as follows:

Global Non-invasive Prenatal Testing Market Revenue (US$ Mn) and Volume (Number of Tests Performed), by Test

  • BambniTest

  • Harmony

  • informaSeq

  • MaterniT21 PLUS

  • NIFTY

  • Panorama

  • PrenaTest

  • verifi

  • VisibiliT

Global Non-invasive Prenatal Testing Market Revenue (US$ Mn) and Volume (Number of Tests Performed), by Geography

  • North America

  • Europe

  • Asia Pacific

  • Rest of the World (RoW)

About Us

Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance.

To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organizations of all sizes.

Contact

Persistence Market Research

305 Broadway

7th Floor, New York City,

NY 10007, United States,

USA - Canada Toll Free: 800-961-0353

Email: sales@persistencemarketresearch.com

media@persistencemarketresearch.com

Web: http://www.persistencemarketresearch.com


Silent Scan Technology Market Projected to Reach CAGR of 5.4% 2016-2026

Adoption of silent scan technology continues to face major challenges, with high cost and a general lack of awareness being the key restraints, according to a new survey by Future Market Insights (FMI). The survey was conducted among respondents from 300 global healthcare facilities, spanning sectors in North America, Latin America, Western Europe, Eastern Europe, Middle East & Africa (MEA), Asia Pacific excluding Japan (APEJ), and Japan. Majority of the respondents in the survey were from the U.S., Canada, Germany, the U.K., the Netherlands, Belgium, Australia, Saudi Arabia and the U.A.E.

Although 44% of responding healthcare facilities currently own an MRI machine with silent- or soft-scan technology, a majority of them were averse to installing one in the future. In addition to high cost of silent scan MRIs and lack of awareness, respondents cited absence of distribution facility and insufficiency of technology as other key factors for not having an MRI machine with silent scan technology.

Request Free Report Sample@ http://www.futuremarketinsights.com/reports/sample/rep-gb-1623

“Silent scan technology is at a nascent stage globally, and although it serves as an effective model for reducing decibel levels, high cost continues to impede its widespread adoption,” said Vrishali Bhagwat, FMI consultant, and co-author of the report Silent Scan Technology Market - Emergence of Private Hospitals Segment as the Most Prominent End User is a Key Factor Driving Revenue Growth. “However, the future looks promising for the technology, as there’s an overall appreciation of the technology, especially among end-users in the private hospitals segment. As technology makes a headway and prices become competitive, adoption is expected to pick up globally.”

FMI’s survey found that adoption varied widely based on the type of healthcare setting. While hospitals are the leading end-users, respondents in private hospitals are more receptive towards the adoption of silent scan technology. Satisfaction with the overall effectiveness of silent scan MRIs is exceedingly high and there’s a sense of understanding that silent scan MRIs do what they promise—quiet, noise-free MRI scans. “Silent scan MRIs received a higher rating than their noisy counterparts from respondents, and this represents an underlying sentiment that the technology per se isn’t the root cause for slow adoption,” added Vrishali.

According to FMI’s market forecast report, silent scan installation base is anticipated to reach 1,815 units in 2016, up from 1,015 units in 2015. Silent scanners constituted 1% of total MRI machine installations in 2015, and owing to their positive reception among end-users, their adoption is expected to witness a steady increase during the forecast period.

Request For TOC@ http://www.futuremarketinsights.com/toc/rep-gb-1623

Hospitals are the leading end-use segment in the global silent scan technology market, and are expected to account for nearly 50% volume share of the market in 2016. Regionally, North America and Asia Pacific excluding Japan (APEJ) are the two largest markets, accounting for over 50% share of the global market in terms of volume. The market in these two regions is dominated by the U.S. and China respectively.

FMI’s report forecasts the global silent scan technology market to increase at a steady compound annual growth rate (CAGR) of 5.4% through 2026.


Urinary Tract Infection Treatment Market Will hit at a CAGR of 2.1% from 2016 to 2026

Over 60% physicians are likely to prescribe penicillin and combinations to treat urinary tract infections (UTIs), whereas a vast majority prescribe quinolones in their daily practice to treat complicated cases. A significant percentage of physicians also agreed that they prescribed nitro furans to treat uncomplicated urinary tract infections in female patients. FMI’s survey also found that cephalosporin is the second-most common drug in the treatment of recurrent and complicated urinary tract infections.

Prevalence of urinary tract infections is higher in females as compared to males, with biologic and behavioral factors accounting for the major causes. Development of this ailment due to genetic causes or urogenital surgery and Estrogen deficiency was minimal.

FMI’s survey also found that prevalence of uncomplicated URI was significantly higher than complicated-, recurring complicated UTIs. However, prevalence of complicated UTI is expected to increase in the future, owing to increase in drug-resistant bacteria and excessive use of antibiotics.

Request Free Report Sample@ http://www.futuremarketinsights.com/reports/sample/rep-gb-1340

The global urinary tract infection treatment market is expected to reach US$ 9.42 Bn in revenues. Complex regulatory requirements and low investment in research and development are some of the key factors for sluggish growth of the market. Clinical trials for designing antibacterial drugs are quite complex, owing to which a number of major companies have decreased their R&D spending on the development of new drugs. Moreover, UTI are not chronic like blood pressure or heart diseases and patients are symptom-free usually within 1-2 weeks of treatment, resulting into limited sales of the drugs. In addition to these factors, economic and regulatory hurdles are also restraining the growth of the urinary tract infection treatment market.

By drug type, quinolones account for the highest revenue share of the global urinary tract infection treatment market. This segment is expected to account for nearly 37.2% share of the global urinary tract infection treatment market revenues in 2016. This represents a market value of nearly US$ 3.5 Bn, up from US$ 3.43 Bn in 2015. Among quinolones, levofloxacin is the most sought-after drug type, representing nearly US$ 1.59 Bn in revenues in 2015. Penicillin and combinations is the second largest drug type, and is expected to total US$ 1.87 Bn in revenues.

Visit For TOC@ http://www.futuremarketinsights.com/toc/rep-gb-1340

Retail pharmacies will continue to remain the largest segment in terms of distribution channel in 2016. This segment accounts for nearly 56.8% revenue share, representing a market value of US$ 5.35 Bn. Gynecology and urology clinics collectively is the second largest segment by distribution channel.

By disease indication, uncomplicated UTI will continue to dominate global revenues. This segment currently accounts for a revenue share of 52.7%, representing a market value of US$ 4.96 Bn in 2016. Neurogenic bladder infections, the second-largest segment by disease indication, is expected to increase by 2.30% in 2016.

Asia Pacific excluding Japan (APEJ) will continue to be the leading market for urinary tract infections, with total revenues expected to reach US$ 3.46 Bn in 2016. Western Europe and North America will remain the second and third largest markets respectively.

Key players operating in the urinary tract infection treatment market include Johnson & Johnson, Boehringer Ingelheim, Cipla Ltd., Bayer AG, GSK, Roche Ltd., Pfizer Inc., Novartis AG, and AstraZeneca plc. The key strategy of a majority of these key players is to expand in emerging markets and achieving inorganic growth through mergers and acquisitions.

Discussion With Analyst@ http://www.futuremarketinsights.com/askus/rep-gb-1340

Long-term Outlook: The global urinary tract infection treatment market is anticipated to increase at a CAGR of 2.1% during the forecast period 2016-2026 and reach US$ 11.58 Bn in revenues.


Flexographic Printing Technology Market: Global Industry Analysis and Forecast 2016 - 2026

Introduction:

Flexography (abbreviated as flexo) is a form of rotary web letterpress, combining features of both rotogravure printing and letterpress which utilizes a flexible relief plate for printing. Flexographic printing is primarily used for printing metallic films, plastic, cellophane and other non-porous substrate which are required for various types of packaging and is well suited for solid colour large area printing application. Its widespread adoption is mainly attributed to two main reasons which are simple printing operation and easy adaptation to the use of water-based inks. The major operations carried out during flexographic printing are image preparation, platemaking, printing and finishing.

Request TOC (table of content), Figures and Table : http://www.persistencemarketresearch.com/toc/11125

Global Flexographic Printing Technology Market Dynamics

The market of global flexographic printing technology is anticipated to be driven by increase in the demand for low cost packaging solutions primarily for food & beverage industry. Moreover, technological advancements in flexographic printing technology such as high quality digital flexographic plates and printing software optimization is mainly driving the consumer preference towards flexographic printing solutions. Besides this, flexographic printing process offers complete product at the end of the process as it includes varnishing, die cutting, lamination, embossing, foiling, etc. which has significantly impacted the growth of the market and is anticipated to be the major growth driver during the forecast period.

Global Flexographic Printing Technology Market Segmentation

The global Flexographic Printing Technology market is segmented on the basis of type of application such as packaging, product label, corrugated print, cardboard boxes, and other products. Among applications, corrugated print segment is expected to hold the largest market share followed by packaging in the global flexographic printing technology market over the forecast period. The global flexographic printing technology market is also segmented on the basis of end-use industries such as food & beverage, pharmaceutical, advertising and household. Under end-use industries, food & beverage segment is expected to hold the highest market share during the forecast period in the global flexographic printing technology market.

Global Flexographic Printing Technology Market: Regional Outlook

Geographically, the Global flexographic printing technology market is segmented by six major regions which include North America, Latin America, Western and Eastern Europe, Asia-Pacific excluding Japan (APEJ), Japan, and Middle East & Africa. The adoption of flexographic printing solutions in various regions is primarily attributed to various factors namely training, consumable costs, and changing perceptions about the flexographic printing process —mainly quality concerns. By region, North America is expected to hold highest market share followed by Europe in the global flexographic printing technology market. However, global growth opportunities mainly lies in the emerging markets where flexographic printing technology is not currently dominant. Rising income and increasing urbanization in these countries, consumers are more likely to purchase packaged foods at retail stores in comparison to fresh foods from local outdoor markets.

Global Flexographic Printing Technology Market Players

The major players identified across the value chain of global Flexographic Printing Technology market include BOBST, SOMA Engineering, Uteco Group, Focus Label Machinery, Consolidated Label Co, Flint Group, Flexographic Printing Plate Co., Inc., de Elliotte Co Inc., Ligum, 3M and others. The companies are emphasizing on research & development and new product development in order to maintain the competitive advantage in global flexographic printing technology market during the forecast period. In order to meet the increasing demand of printing seamless motives and high resistance to solvent, companies all over the world are focusing towards the development of sleeves types and rollers in order to expand their product portfolio and increase global footprint. The companies are also focusing on different strategies in order to maintain the market share in the global flexographic printing technology market.

To Buy This Report : http://www.persistencemarketresearch.com/checkout/11125

The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to categories such as market segments, geographies, types and applications.

The report covers exhaustive analysis on:

  • Market Segments

  • Market Dynamics

  • Market Size

  • Supply & Demand

  • Current Trends/Issues/Challenges

  • Competition & Companies involved

  • Value Chain

Regional analysis includes:

  • North America

  • Latin America

  • Asia Pacific

  • Japan

  • Western Europe

  • Eastern Europe

  • Middle East & Africa

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts, and industry participants across the value chain. The report provides an in-depth analysis of parent market trends, macroeconomic indicators and governing factors, along with market attractiveness within the segments. The report also maps the qualitative impact of various market factors on market segments and various geographies.

Report highlights:

  • Detailed overview of parent market

  • Changing market dynamics in the industry

  • In-depth market segmentation

  • Historical, current and projected market size in terms of volume and value

  • Recent industry trends and developments

  • Competitive landscape

  • Strategies of key players and products offered

  • Potential and niche segments, geographical regions exhibiting promising growth

  • A neutral perspective on market performance

  • Must-have information for market players to sustain and enhance their market footprint

PMR for Journalist: http://www.persistencemarketresearch.com/page/journalist-resources.asp

About Us

Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance.

To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organizations of all sizes.

Contact

Persistence Market Research

305 Broadway

7th Floor, New York City,

NY 10007, United States,

USA - Canada Toll Free: 800-961-0353

Email: sales@persistencemarketresearch.com

media@persistencemarketresearch.com

Web: http://www.persistencemarketresearch.com


Continuous Peripheral Nerve Block Catheter Market worth US$ 698.9 Mn by 2016-2026

Continuous peripheral nerve block catheters are gaining traction in the healthcare sector as an effective analgesic for pain management. The global market for continuous peripheral never block catheters (CPNBC) was valued at US$ 372.8 Mn in 2015, and is expected to witness a year-over-year growth of 4.9% to reach US$ 391.2 Mn in 2016.

Increasing prevalence of osteoarthritis and effectiveness of CPNBC in upper/lower extremity joint replacement procedures will continue to fuel growth of the market in 2016. Other factors, such as cost-effectiveness and lower hospital stay are also making continuous peripheral never block catheters an appealing option for analgesia among healthcare professionals. However, longstanding challenges, such as lack of trained professionals and ambiguity over standard usage guidelines are anticipated to pose challenges to widespread adoption.

The U.S. will continue to be at the forefront of adoption of continuous peripheral nerve block catheters, making North America the most lucrative market globally. North America’s revenue share in the global CPNBC market is expected to reach 42.4% in 2016. Western Europe is the second-largest market, with total revenues reaching US$ 61.3 Mn in 2016.

By product, non-stimulating catheter systems account for the highest demand—in 2016, global revenues are anticipated to total US$ 220.8 Mn. On the other hand, the over-the-needle product segment will witness lowest demand in 2016 and beyond.

Request Free Report Sample@ http://www.futuremarketinsights.com/reports/sample/rep-gb-1307

By insertion technique, ultrasound insertion is gaining traction over nerve stimulation although the latter accounts for the majority revenue share of the market currently. Ultrasound insertion revenues are anticipated to grow by 5.8% in 2016, whereas over nerve stimulation revenues will grow by 4.5%.

By indication, lower extremity surgeries will continue to be the leading segment, accounting for US$ 119.8 Mn in 2016, an increase of 5.3% over 2015. Adoption of CPNBC in lower extremity surgeries is anticipated to be quite robust, and this segment will witness higher growth than other indication segments.

By end-user, hospitals will continue to maintain their dominance over ambulatory surgical centres in 2016 as well. The hospitals segment of the continuous peripheral nerve block catheters market is expected to reach US$ 243.4 Mn in revenues in 2016, witness a growth of 5.3% over 2015.

Request For TOC@ http://www.futuremarketinsights.com/toc/rep-gb-1307

B.Braun Melsungen AG is the largest player in the continuous peripheral nerve block cathether market. It has a broad product portfolio and its products have been positively received in the market. Other key players in the market include Halyard Health, Inc., Ambu A/S, Epimed International Inc., Teleflex Incorporated, and Pajunk GmbH.

Long-term Outlook: The global continuous peripheral nerve block catheters market is anticipated to increase at 6% CAGR during the forecast period 2016-2026. North America will continue to be the largest market, whereas rising awareness will led to higher adoption in developing countries.


Big Data Market: dominated by North America with high market shares through 2020

The Big data can be defined as the capture, curation, storage, search and analysis of large and complex data sets which are otherwise difficult to be process or handle by traditional data processing systems. These systems are currently being implemented on a limited scale in many supply chain companies for varied purposes. There is huge scope and demand for the Big Data Market due to increasing involvement of technology during 2015-2020.

Scope and regional forecast of the Big Data Market:

In Big Data Market, nearly every large scale IT vendor maintains a Big Data portfolio. At present, the market is largely dominated by hardware sales and professional services in terms of revenue. Going forward, software vendors, particularly those in the Big Data analytics segment, are expected to significantly increase their stake in this market.

In Big Data Market, Amidst the proliferation of real time data from sources such as mobile devices, web, social media, sensors, log files and transactional applications; Big Data has found a host of vertical market applications ranging from fraud detection to scientific R&D. Data mining is done on these massive datasets.

According to IndustryARC market research report, Big Data Market is led by US in North America, followed by Europe and APAC regions. The US has the major shares of this technology through 2020. North America has many big data companies that provide big data solutions and big data analytics tools to other companies as a service.

Asia Pacific is a potential region with high scope for this market for huge implementation and big data analytics through 2020. India and China are potential countries for implementing big data solutions.

For More Info @ http://www.industryarc.com/inquiry-before-buying.php?id=71

Segmentation and key players in the Big Data Market:

The Big Data Market is segmented into various categories in the IndustryARC market analysis studies by providers.

By providers: IBM, HP, Teradata, Oracle, SAP, EMC, Amazon, Microsoft, Google, VMware, Cloudera, Splunk, Hortonworks, MongoDB and MapR

The key players in the Big Data Market as mentioned in the IndustryARC market research analysis report are as follows:

  • Amazon
  • IBM
  • Data Direct Networks
  • Cloudera
  • Pentaho Corporation

The Big Data Market is an emerging innovative market that has great scope in upcoming term in technology, business and research sectors. It can be used in research purposes to find trends and patterns in business and evaluation of human behavior. This market is expected to have high growth due to huge investments made in this technology and utilization of this big data technology during 2015-2020.

Request Sample PDF Brochure @ http://industryarc.com/pdfdownload.php?id=71

About IndustryARC:
IndustryARC is a Research and consulting firm that publishes more than 500 Reports Annually in various industries, such as Agriculture, Automotive, Automation & Instrumentation, Chemicals and Materials, Energy and Power, Electronics, Food & Beverages, Information Technology, Life sciences & Healthcare.


IndustryARC primarily focuses on Cutting Edge Technologies and Newer Applications of the Market. Our Custom Research Services are designed to provide insights on the constant flux in the global demand-supply gap of markets. Our strong analyst team enables us to meet the client research needs at a very quick speed with a variety of options for your business.


We look forward to support the client to be able to better address customer needs; stay ahead in the market; become the top competitor and get real-time recommendations on business strategies and deals. Contact us to find out how we can help you today.

Media Contact
Contact Person: Sanjay Matthews
Email: sales@industryarc.com
Phone: 1-614-588-8538 (Ext: 101)
Company Name: IndustryARCTM
Connect with us on LinkedIn @ http://www.linkedin.com/company/industryarc
Get More Insights on Reports @ http://goo.gl/Ga7fq7



connect